All In Biotech

Drug Trial Radar · NCT05776914

Fecal Microbiota Transplantation for IBS

Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)

Last checked: Nov 20, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

43

Planned (sponsor's estimate)

Start

Apr 15, 2024

Primary completion

Jun 26, 2027

Study completion Jun 26, 2027

Sponsor

Lead sponsor
Madhusudan (Madhu) Grover, MBBSAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 20, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

Conditions

  • Irritable Bowel Syndrome
  • Diarrhea

Interventions

  • Donor Fecal Microbiota TransplantationBiological

    Single fecal microbiota transplantation using 50 gm of freeze-thawed donor stool

  • Autologous Fecal Microbiota TransplantationBiological

    Single fecal microbiota transplantation using 50 gm of stool collected from the same individual

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of respondersTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic in Minnesota

    Rochester, Minnesota · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.